Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Q&A: Data Gaps Hinder Monitoring of SARS-COV-2 Variants
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
Martha Nelson of the National Institute of Allergy and Infectious Diseases talks about the need to balance data sharing and patient privacy concerns when tracking the spread of variants.
With many millions of people waiting several weeks to receive a second COVID-19 vaccine dose in some countries, experts consider the possibility that SARS-CoV-2 could evolve vaccine resistance.
A study explains how Zika was present among mosquitoes in Africa for decades without causing the harm to human health seen outside the continent in recent years.
There have been no reports of health or environmental harm in other locations where genetically modified mosquitoes have been introduced over the last decade.
In recent years, laboratories on the continent have ramped up genomic sequencing capabilities, offering in-country analyses rather than outsourcing the job.
The biotech Oxitec had released the genetically engineered insects with the hope that they would breed with wild populations and produce offspring that die young. But that’s not always happening.